EyeCity.com, Inc.

OTC: ICTY · Healthcare · Medical - Specialties

PublicHQ Land of Lakes, FLReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 38DQ —GM —SS 56

v0.1 · 35/100 weight · pillars only

↑ listing tenure, return on assets · ↓ Piotroski F, balance-sheet leverage

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$200.4k

Employees

Market cap

$455.6k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02025

Net income-$200.4k-$200.4k2025

Operating income-$200.4k-$200.4k2025

Total assets$848.0k$848.0k2025

Liabilities$1.4M$1.4M2025

Equity-$533.6k-$533.6k2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

EyeCity.com, Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Canopus Biopharma, Inc.——OJsys, Inc.——Vibe Growth Corporation58C Halberd Corporation——

Key facts

CEOBradley R. Wilson

SectorHealthcare

IndustryMedical - Specialties

HeadquartersLand of Lakes, FL

ExchangeOTC: ICTY

Employees59

IPO date1998-01-14

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.